A J Scheen Selected Research

A J Scheen Research Topics

Disease

142	Type 2 Diabetes Mellitus (MODY) 01/2023 - 03/2000
47	Insulin Resistance 09/2017 - 01/2000
35	Weight Loss (Weight Reduction) 01/2023 - 03/2000
30	Cardiovascular Diseases (Cardiovascular Disease) 01/2023 - 01/2000
28	Heart Failure 11/2022 - 01/2003
26	Hypertension (High Blood Pressure) 01/2020 - 01/2000
22	Obesity 01/2023 - 01/2000
21	Body Weight (Weight, Body) 01/2023 - 03/2000
18	Type 1 Diabetes Mellitus (Autoimmune Diabetes) 04/2019 - 03/2000
17	Myocardial Infarction 11/2018 - 12/2000
17	Diabetes Mellitus 10/2015 - 02/2000
16	Weight Gain 05/2020 - 04/2002
16	Metabolic Syndrome (Dysmetabolic Syndrome X) 01/2014 - 04/2000
15	Coronary Disease (Coronary Heart Disease) 09/2017 - 09/2000
14	Stroke (Strokes) 09/2017 - 10/2000
13	Overweight 01/2019 - 09/2001
12	Renal Insufficiency (Renal Failure) 03/2022 - 11/2009
12	Glucose Intolerance 04/2010 - 03/2000
9	Morbid Obesity 09/2012 - 03/2000
8	Lactic Acidosis 03/2021 - 05/2002
8	Acute Coronary Syndrome 09/2015 - 03/2004
7	Chronic Renal Insufficiency 01/2023 - 08/2012
7	Inflammation (Inflammations) 05/2022 - 10/2009
7	Coronary Artery Disease (Coronary Atherosclerosis) 08/2013 - 07/2002
6	Chronic Kidney Failure (Chronic Renal Failure) 01/2022 - 05/2005
5	Albuminuria 01/2023 - 12/2005
5	Infections 11/2022 - 03/2004
5	COVID-19 03/2021 - 01/2020
5	Neoplasms (Cancer) 12/2018 - 12/2002
5	Diabetes Complications 12/2018 - 05/2000
5	Atherosclerosis 06/2015 - 04/2003
4	Fatty Liver 01/2023 - 04/2000
4	Hemorrhage 02/2021 - 09/2006
4	Atrial Fibrillation 02/2021 - 10/2009
4	Breast Neoplasms (Breast Cancer) 12/2018 - 09/2009
4	Thrombosis (Thrombus) 04/2011 - 03/2001

Drug/Important Bio-Agent (IBA)

72	Glucose (Dextrose)FDA LinkGeneric 01/2023 - 01/2000
70	Insulin (Novolin)FDA Link 11/2022 - 01/2000
52	Metformin (Glucophage)FDA LinkGeneric 11/2022 - 03/2000
21	Hypoglycemic Agents (Hypoglycemics)IBA 05/2020 - 05/2001
20	Sodium-Glucose Transporter 2 InhibitorsIBA 01/2023 - 08/2011
17	LipidsIBA 09/2015 - 05/2000
17	Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA 09/2015 - 12/2002
14	ThiazolidinedionesIBA 11/2008 - 03/2000
13	Sodium-Glucose Transport ProteinsIBA 01/2023 - 11/2015
12	Dipeptidyl-Peptidase IV InhibitorsIBA 11/2022 - 08/2010
12	Angiotensin-Converting Enzyme Inhibitors (ACE Inhibitors)IBA 02/2021 - 02/2000
11	Glucagon-Like Peptide 1 (GLP 1)IBA 01/2023 - 06/2004
10	LDL CholesterolIBA 12/2022 - 03/2004
10	HDL CholesterolIBA 03/2019 - 02/2005
9	empagliflozinIBA 01/2023 - 09/2015
9	Antihypertensive Agents (Antihypertensives)IBA 02/2021 - 01/2003
9	Sitagliptin Phosphate (Januvia)FDA Link 09/2020 - 02/2008
9	Pioglitazone (Actos)FDA Link 12/2018 - 01/2001
9	sibutramine (Meridia)FDA Link 10/2010 - 03/2000
8	DiureticsIBA 04/2018 - 01/2000
8	Rosiglitazone (Avandia)FDA Link 10/2010 - 01/2001
7	CholesterolIBA 12/2022 - 12/2000
7	Atorvastatin (Lipitor)FDA Link 02/2021 - 12/2000
7	CytokinesIBA 01/2020 - 04/2000
7	Triglycerides (Triacylglycerol)IBA 03/2019 - 01/2006
7	IncretinsIBA 12/2014 - 08/2007
7	Blood Glucose (Blood Sugar)IBA 02/2014 - 05/2000
7	Orlistat (Xenical)FDA Link 05/2005 - 03/2000
6	Liraglutide FDA Link 01/2023 - 11/2008
6	Glucagon-Like Peptide-1 Receptor AgonistsIBA 11/2022 - 08/2007
6	Perindopril FDA LinkGeneric 02/2021 - 11/2001
6	BiguanidesIBA 11/2020 - 06/2001
6	CreatinineIBA 01/2019 - 05/2009
6	Amlodipine (Norvasc)FDA LinkGeneric 10/2014 - 01/2003
6	RimonabantIBA 05/2008 - 05/2005
5	Glucagon (Glukagon)FDA Link 01/2023 - 11/2010
5	oxidized low density lipoproteinIBA 12/2022 - 03/2004
5	Aspirin (Acetylsalicylic Acid)FDA LinkGeneric 05/2022 - 03/2001
5	Insulin Glargine (Lantus)FDA Link 04/2019 - 02/2004
5	Exenatide (Byetta)FDA Link 04/2014 - 06/2004
5	Angiotensin Receptor AntagonistsIBA 04/2008 - 02/2001
5	AdiponectinIBA 01/2008 - 09/2003
4	dapagliflozinIBA 01/2023 - 08/2011
4	ReninIBA 01/2020 - 05/2003
4	Fenofibrate (CiL)FDA LinkGeneric 03/2019 - 12/2005
4	Glucagon-Like Peptide-1 ReceptorIBA 02/2019 - 01/2018
4	Biomarkers (Surrogate Marker)IBA 01/2019 - 04/2000
4	glimepiride (Amarel)FDA LinkGeneric 11/2018 - 03/2000
4	Short-Acting InsulinIBA 10/2015 - 04/2002
4	Acarbose FDA LinkGeneric 01/2013 - 10/2001
4	Hormones (Hormone)IBA 08/2012 - 12/2005
4	2,4-thiazolidinedione (thiazolidinedione)IBA 04/2012 - 12/2004
4	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 08/2011 - 03/2000
4	Fibric Acids (Fibrates)IBA 09/2010 - 05/2003
4	Anti-Obesity Agents (Antiobesity Drugs)IBA 01/2010 - 03/2000
4	Ramipril (Altace)FDA LinkGeneric 04/2008 - 02/2000
3	CanagliflozinIBA 01/2023 - 12/2014

Therapy/Procedure

63	Therapeutics 01/2023 - 01/2000
15	Glycemic Control 02/2012 - 03/2000
10	Secondary Prevention 10/2019 - 02/2000
9	Bariatric Surgery 09/2012 - 03/2000
5	Injections 01/2020 - 02/2004
5	Contraindications 08/2013 - 01/2010
4	Stents 11/2008 - 03/2001